Equifax Investing Cash Flow increased by 40.9% to -$120.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 12.3%, from -$107.20M to -$120.40M. Over 4 years (FY 2021 to FY 2025), Investing Cash Flow shows an upward trend with a -36.4% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$122.10M | -$344.70M | -$1.96B | -$268.20M | -$60.50M | -$478.40M | -$152.40M | -$162.60M | -$156.10M | -$406.00M | -$153.50M | -$131.90M | -$136.70M | -$124.00M | -$118.90M | -$107.20M | -$121.40M | -$122.00M | -$203.70M | -$120.40M |
| QoQ Change | — | -182.3% | -468.0% | +86.3% | +77.4% | -690.7% | +68.1% | -6.7% | +4.0% | -160.1% | +62.2% | +14.1% | -3.6% | +9.3% | +4.1% | +9.8% | -13.2% | -0.5% | -67.0% | +40.9% |
| YoY Change | — | — | — | — | +50.5% | -38.8% | +92.2% | +39.4% | -158.0% | +15.1% | -0.7% | +18.9% | +12.4% | +69.5% | +22.5% | +18.7% | +11.2% | +1.6% | -71.3% | -12.3% |